Galectin Therapeutics Inc. (GALT) P/B ratio

P/B ratio · fiscal 2021
135.7×

Only 2 fiscal years of P/B ratio are on record here for Galectin Therapeutics Inc. (GALT); a history needs at least 3. Figures as of 18 Nov 2026, 12:04 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

P/B ratio, fiscal 2021
135.7×
Change on fiscal 2020
+2286.4%
Fiscal years on record
22020–2021

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Figures, not advice.

Not enough data

A history of P/B ratio needs at least 3 fiscal years; 2 are on record here for Galectin Therapeutics Inc.. Nothing is estimated to fill the gap. What is on record is in the table below.

Galectin Therapeutics Inc. P/B ratio, year by year

Galectin Therapeutics Inc. (GALT) P/B ratio by fiscal year
Fiscal yearP/B ratioChangeYear endedShare price at year-endBook value per share
2025——$4.16-$1.97
2024——$1.29-$1.65
2023——$1.66-$1.00
2022——$1.13-$0.54
2021135.7× 2,286.4% up$2.07$0.02
20205.7×—$2.24$0.39
2019——$2.86—
2018——$3.43—
2017——$3.34—
2016——$0.98—
2015——$1.64—
2014——$3.47—
2013——$8.08—
2012——$2.05—
2011——$5.76—
2010——$5.40—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

The P/B ratio is the share price divided by book value per share — shareholders' equity on the balance sheet divided by the share count — at each fiscal year-end; a year with negative equity has no P/B.

How to read it

It compares the price with the accounting value of what the company owns net of what it owes, and matters most for banks, insurers and other balance-sheet businesses.

More on GALT

Galectin Therapeutics Inc., figure by figure

Galectin Therapeutics Inc. (GALT) overview: price, valuation and scorecard

Galectin Therapeutics Inc. P/B ratio: questions and answers

How is Galectin Therapeutics Inc.'s P/B ratio calculated?

The P/B ratio is the share price divided by book value per share — shareholders' equity on the balance sheet divided by the share count — at each fiscal year-end; a year with negative equity has no P/B. For Galectin Therapeutics Inc. it is on record here for 2 fiscal years, 2020 to 2021.

Share prices are Yahoo Finance's monthly closes: a fiscal year-end is paired with the close of the month it falls in, and today's quote may be delayed. Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Galectin Therapeutics Inc. (GALT) P/B ratio”, data as of 18 November 2026. https://funkfolio.com/stock/GALT/pb-ratio

Underlying data: the company's filings with the SEC and Yahoo Finance.